PON1 and prostate carcinoma: Research has shown that androgens can significantly increase the expression of CYP4F2 and CYP4F3 through androgen receptor (AR) in prostate cancer cells (52), while PON1 activity is modulated by estrogen through HDL metabolism pathways (53).